Data / Form D filings / DILON TECHNOLOGIES INC
DILON TECHNOLOGIES INC: Form D filings
DILON TECHNOLOGIES INC, a biotechnology company in Newport News, VA, filed 25 Form D notices with the SEC between 2008 and 2026. The latest, on March 11, 2026, reports $8.1 million sold of a $10.4 million offering to 184 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 MARINERS ROW SUITE 200, Newport News, VA, 23606
- Phone
- (757) 269-4910
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1047810
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Amendment | $10,400,000 | $8,056,500 | $2,343,500 | 184 | May 23, 2025 | sec.gov |
| Jul 8, 2025 | New notice | $10,000,000 | $1,889,000 | $8,111,000 | 46 | May 23, 2025 | sec.gov |
| Jan 14, 2025 | Amendment | $30,000,000 | $21,098,500 | $8,901,500 | 148 | Jan 31, 2024 | sec.gov |
| Jan 30, 2024 | New notice | $10,000,000 | $4,685,000 | $5,315,000 | 69 | Oct 13, 2023 | sec.gov |
| Apr 21, 2023 | New notice | $7,500,000 | $2,727,000 | $4,773,000 | 17 | Mar 28, 2023 | sec.gov |
| Oct 11, 2022 | New notice | $8,000,000 | $4,615,000 | $3,385,000 | 39 | Sep 28, 2022 | sec.gov |
| Feb 24, 2022 | Amendment | $10,000,000 | $4,090,000 | $5,910,000 | 49 | Oct 26, 2021 | sec.gov |
| Dec 3, 2021 | New notice | $5,000,000 | $1,930,000 | $3,070,000 | 22 | Oct 26, 2021 | sec.gov |
| Feb 8, 2018 | Amendment | $5,450,000 | $5,137,750 | $312,250 | 81 | Dec 18, 2017 | sec.gov |
| Jan 19, 2018 | New notice | $5,450,000 | $1,853,000 | $3,597,000 | 34 | Dec 18, 2017 | sec.gov |
| Dec 31, 2013 | New notice | $5,800,000 | $3,953,200 | $1,846,800 | 107 | Dec 17, 2013 | sec.gov |
| Nov 15, 2011 | Amendment | $3,000,000 | $1,920,000 | $1,080,000 | 20 | May 5, 2011 | sec.gov |
| Sep 13, 2011 | Amendment | $1,500,000 | $1,200,000 | $300,000 | 4 | May 5, 2011 | sec.gov |
| Mar 30, 2011 | Amendment | $1,500,000 | $875,000 | $625,000 | 39 | Nov 11, 2008 | sec.gov |
| Feb 22, 2011 | Amendment | $1,500,000 | $305,000 | $1,195,000 | 9 | Nov 11, 2008 | sec.gov |
| Nov 24, 2010 | Amendment | $1,500,000 | $414,000 | $1,086,000 | 4 | Nov 24, 2008 | sec.gov |
| Sep 1, 2010 | Amendment | $3,350,000 | $2,954,000 | $396,000 | 196 | Nov 24, 2008 | sec.gov |
| Apr 15, 2010 | Amendment | $3,000,000 | $2,175,000 | $825,000 | 196 | Nov 24, 2008 | sec.gov |
| Jul 2, 2009 | Amendment | $3,000,000 | $1,697,200 | $1,302,800 | 73 | Nov 24, 2008 | sec.gov |
| Jun 29, 2009 | New notice | $2,000,000 | $749,500 | $1,250,500 | 16 | Nov 24, 2008 | sec.gov |
| Feb 26, 2009 | Amendment | $1,250,000 | $660,800 | $589,200 | 37 | Nov 24, 2008 | sec.gov |
| Feb 26, 2009 | Amendment | $2,000,000 | $749,500 | $1,250,500 | 16 | Nov 24, 2008 | sec.gov |
| Nov 12, 2008 | Amendment | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Nov 12, 2008 | New notice | $1,250,000 | $0 | $1,250,000 | 0 | Yet to occur | sec.gov |
| Nov 12, 2008 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert G. Moussa | Director | |
| Rachel F. Brem | Director | |
| Michael N. Taglich | Director | |
| Francis Bissaillon | Director | |
| George N. Makhoul | Executive Officer, Director | |
| Tim Jette | Executive Officer | |
| Robert Taglich | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Mar 9, 2026 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what DILON TECHNOLOGIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.